SEC Form 4 · accession 0001225208-26-007408
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew M. Dahl
Officer — SVP, Corporate Controller
Period of report
Aug 31, 2026
Accepted (ET)
Aug 31, 2026 · 5:47 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 31, 2026 | S | 544 | $91.055 | D | 14,868 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.